Unpaste

Description

Mint 10 Tablets are formulated for oral administration. Each tablet contains an active ingredient designed for therapeutic use. The product is identified by the National Drug Code (NDC) 74355-666-11. The tablets are presented in a standard dosage form, suitable for patient consumption.

Uses and Indications

This drug is indicated for the prevention of dental cavities. It is intended for use in individuals at risk of developing dental caries.

Dosage and Administration

Adults and children aged 6 years and older are instructed to chew one tablet briefly and then brush their teeth thoroughly. This should be performed preferably after each meal or at least twice daily, unless otherwise directed by a dentist or physician. It is important to note that the tablet should not be swallowed.

For children under 6 years of age, supervision is required during the brushing and rinsing process to ensure safety and proper technique.

Contraindications

Use of this product is contraindicated in the following situations:

Accidental ingestion of amounts exceeding those recommended for brushing requires immediate medical attention or contact with a Poison Control Center.

Discontinue use if irritation or sensitivity occurs during application.

Warnings and Precautions

When using this product, it is imperative to monitor for any signs of irritation or sensitivity. Should such reactions occur, the use of the product must be discontinued immediately to prevent further complications.

This product should be stored out of the reach of children. In the event that more than the recommended amount used for brushing is accidentally ingested, it is crucial to seek medical assistance or contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware of potential adverse reactions. In the event of irritation or sensitivity, it is advised to discontinue use immediately.

Additionally, it is crucial to keep the product out of the reach of children. If a patient accidentally swallows more than the amount intended for brushing, they should seek medical assistance or contact a Poison Control Center without delay.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Unpaste (zero waste fluoride mint tooth tabs). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 years and older are advised to chew one tablet briefly and brush their teeth thoroughly, preferably after each meal or at least twice a day, or as directed by a dentist or doctor. For children under 6 years of age, supervision during brushing and rinsing is essential to ensure safety and proper use.

It is important to keep the product out of the reach of children. In the event that more than the recommended amount is accidentally swallowed, medical assistance should be sought immediately, or contact a Poison Control Center for guidance.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific information is available.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the lack of detailed guidance necessitates careful clinical judgment and individualized patient assessment. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is crucial to ensure that the product is kept out of the reach of children. Accidental ingestion of amounts exceeding those typically used for brushing may necessitate immediate medical intervention.

Healthcare professionals should advise caregivers to seek medical assistance or contact a Poison Control Center without delay if such an incident occurs. Prompt action is essential to mitigate potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if more than the recommended amount of the product is accidentally swallowed. It is important for patients to understand the potential risks associated with improper use.

Additionally, healthcare providers should instruct patients to discontinue use of the product if they experience any irritation or sensitivity. Patients should be encouraged to report any adverse reactions to their healthcare provider to ensure appropriate management and care.

Storage and Handling

The product is supplied in packaging that ensures its integrity during storage and handling. It should be stored at a temperature range of 25-30°C (68-77°F) to maintain its efficacy. Additionally, it is essential to protect the product from excessive moisture to prevent degradation. Proper adherence to these storage conditions is crucial for preserving the quality of the product.

Additional Clinical Information

The product is administered via the dental route. Patients, including adults and children aged 6 years and older, are instructed to chew one tablet briefly and then brush their teeth thoroughly, preferably after each meal or at least twice daily, or as directed by a dentist or doctor.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Unpaste, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)